Nunc orci fringilla tellus erat dignissim primis
Researchers at University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat diabetes and obesity, may help reduce liver scarring in patients with advanced fatty liver disease, including those with early-stage cirrhosis
Results indicated that BPC 157 increased the speed of tendon explant outgrowth
Piticchio T, Frasca F, Malandrino P, Trimboli P, Carrubba N, Tumminia A et al (2023) Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis
4,6 Conclusion In general, DPP-4 inhibitors are effective at promoting moderate lowering of A1C and are associated with few adverse events
Please consult a qualified health professional before making any significant changes to your diet or lifestyle, especially if you have existing medical conditions